HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

1,2-bis(3,5-dioxopiperazin-1-yl)ethane

Also Known As:
ICRF 154; ICRF-154
Networked: 11 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Lu, Da-Yong: 3 articles (09/2010 - 07/2006)
2. Lu, Ting-Ren: 2 articles (09/2010 - 01/2010)
3. Huang, Min: 2 articles (07/2006 - 01/2005)
4. Ding, Jian: 2 articles (07/2006 - 01/2005)
5. Hasegawa, Leslie S: 1 article (01/2013)
6. Vuong, Minh C: 1 article (01/2013)
7. Eastmond, David A: 1 article (01/2013)
8. Xu, Cheng-Hui: 1 article (07/2006)
9. Zhu, Hong: 1 article (07/2006)
10. Xu, Bin: 1 article (07/2006)

Related Diseases

1. Lymphoma (Lymphomas)
2. Neoplasms (Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Psoriasis (Pustulosis Palmaris et Plantaris)
5. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

Related Drugs and Biologics

1. sobuzoxane
2. 3,6- bis(5- chloro- 2- piperidyl)- 2,5- piperazinedione
3. Razoxane (Dexrazoxane)
4. bimolane
5. 4,4'- (1,2- dimethyl- 1,2- ethanediyl)bis- 2,6- piperazinedione
6. Topoisomerase II Inhibitors
7. Type II DNA Topoisomerases (Topoisomerase II)
8. DNA (Deoxyribonucleic Acid)